DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA18

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. DOI:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Lee M, Ko H, Yun M. 2018. Cancer metabolism as a mechanism of treatment resistance and potential therapeutic target in hepatocellular carcinoma. Yonsei Med J. 59(10):1143–1149. DOI:10.3349/ymj.2018.59.10.1143
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao X, Jiang P, Xiao S, Wu G, Chen K, Zhang X, Liu H, Han X, Wang S, et al. 2016. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: a retrospective case-control study. Medicine. 95(31):e4224. DOI:10.1097/MD.0000000000004224
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H. 2010. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol. 53(1):132–144. DOI:10.1016/j.jhep.2010.02.027
   PubMed Web of Science ®Google Scholar
• Avila M, Berasain C. 2015. Making sorafenib irresistible: in vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14. Hepatology. 61(5):1755–1757. DOI:10.1002/hep.27739
   PubMed Web of Science ®Google Scholar
• Chan L-K, Ho DW, Kam CS, Chiu EY, Lo IL, Yau DT, Cheung ETY, Tang C-N, Tang VWL, Lee TKW, et al. 2021. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma. J Hepatol. 74(2):360–371. DOI:10.1016/j.jhep.2020.08.036
   PubMed Web of Science ®Google Scholar
• Dong XF, Liu TQ, Zhi XT, Zou J, Zhong JT, Li T, Mo X-L, Zhou W, Guo -W-W, Liu X, et al. 2018. COX-2/PGE2 axis regulates hif2α activity to promote hepatocellular carcinoma hypoxic response and reduce the sensitivity of sorafenib treatment. Clin Cancer Res. 24(13):3204–3216. DOI:10.1158/1078-0432.CCR-17-2725
   PubMed Web of Science ®Google Scholar
• Linder P, Jankowsky E. 2011. From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 12(8):505–516. DOI:10.1038/nrm3154
   PubMed Web of Science ®Google Scholar
• Linder P, Fuller-Pace FV. 2013. Looking back on the birth of DEAD-box RNA helicases. Biochim Biophys Acta. 1829(8):750–755. DOI:10.1016/j.bbagrm.2013.03.007
   PubMed Web of Science ®Google Scholar
• Pang P, Hu X, Zhou B, Mao J, Liang Y, Jiang Z, Huang M, Liu R, Zhang Y, Qian J, et al. 2019. DDX24 mutations associated with malformations of major vessels to the viscera. Hepatology. 69:803–816. DOI:10.1002/hep.30200
   PubMed Web of Science ®Google Scholar
• Shi D, Dai C, Qin J, Gu W. 2016. Negative regulation of the p300-p53 interplay by DDX24. Oncogene. 35(4):528–536. DOI:10.1038/onc.2015.77
   PubMed Web of Science ®Google Scholar
• Oliver D, Ji H, Liu P, Gasparian A, Gardiner E, Lee S, Zenteno A, Perinskaya LO, Chen M, Buckhaults P, et al. 2017. Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen. Sci Rep. 7:43023. DOI:10.1038/srep43023
   PubMed Web of Science ®Google Scholar
• Lui L, Lowe T. 2013. Small nucleolar RNAs and RNA-guided post-transcriptional modification. Essays Biochem. 54:53–77. DOI:10.1042/bse0540053
   PubMed Web of Science ®Google Scholar
• Lafontaine DL, Tollervey D. 1998. Birth of the snoRNPs: the evolution of the modification-guide snoRNAs. Trends Biochem Sci. 23(10):383–388. DOI:10.1016/s0968-0004(98)01260-2
   PubMed Web of Science ®Google Scholar
• Kiss T. 2002. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell. 109(2):145–148. DOI:10.1016/s0092-8674(02)00718-3
   PubMed Web of Science ®Google Scholar
• Shuwen H, Xi Y, Quan Q, Yin J, Miao D. 2020. Can small nucleolar RNA be a novel molecular target for hepatocellular carcinoma? Gene. 733:144384. DOI:10.1016/j.gene.2020.144384
   PubMed Web of Science ®Google Scholar
• Taniuchi K, Ogasawara M. 2020. KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer. Oncotarget. 11:131–147. DOI:10.18632/oncotarget.27413
   PubMedGoogle Scholar
• Kitagawa T, Taniuchi K, Tsuboi M, Sakaguchi M, Kohsaki T, Okabayashi T, Saibara T. 2019. Circulating pancreatic cancer exosomal RNA s for detection of pancreatic cancer. Mol Oncol. 13(2):212–227. DOI:10.1002/1878-0261.12398
   PubMed Web of Science ®Google Scholar
• Chen CT, Wu PH, Hu CC, Nien HC, Wang JT, Sheu JC, Chow LP. Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 promotes proliferation and metastasis of hepatocellular carcinoma cells via coordinated activation of AhR and β-Catenin Signaling. Int J Mol Sci. 2021;22:21. DOI:10.3390/ijms222111661.
   Web of Science ®Google Scholar
• Lv J, Zhang S, Wu H, Lu J, Lu Y, Wang F, Zhao W, Zhao P, Lu J, Fang Q, et al. 2020. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2. Cancer Lett. 469:22–34. DOI:10.1016/j.canlet.2019.10.025
   PubMed Web of Science ®Google Scholar
• Xiaoqian W, Bing Z, Yangwei L, Yafei Z, Tingting Z, Yi W, Qingjun L, Suxia L, Ling Z, Bo W, et al. DEAD-box Helicase 27 promotes hepatocellular carcinoma progression through ERK Signaling. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211055953. DOI:10.1177/15330338211055953
   Web of Science ®Google Scholar
• Yu Y, Zhao D, Li K, Cai Y, Xu P, Li R, Li J, Chen X, Chen P, Cui G. 2020. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway. Cell Death Dis. 11(4):273. DOI:10.1038/s41419-020-2478-0
   PubMed Web of Science ®Google Scholar
• Lokau L, Schoeder S, Haybaeck H, Garbers G. 2019. Jak-stat signaling induced by interleukin-6 family cytokines in hepatocellular carcinoma. Cancers. 11(11):1704. DOI:10.3390/cancers11111704
   PubMed Web of Science ®Google Scholar
• Al-Rajabi R, Patel S, Ketchum NS, Jaime NA, Lu T-W, Pollock BH, Mahalingam D. 2015. Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction. J Gastrointest Oncol. 6(3):259–267. DOI:10.3978/j.2078-6891.2015.005
   PubMedGoogle Scholar
• Liang Y, Chen J, Yu Q, Ji T, Zhang B, Xu J, Dai Y, Xie Y, Lin H, Liang X, et al. 2017. Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma. Cancer Med. 6(12):2787–2795. DOI:10.1002/cam4.1228
   PubMed Web of Science ®Google Scholar
• Nishida N, Kitano M, Sakurai T, Kudo M. 2015. Molecular mechanism and prediction of sorafenib chemoresistance in human hepatocellular carcinoma. Dig Dis. 33(6):771–779. DOI:10.1159/000439102
   PubMed Web of Science ®Google Scholar
• Fornari F, Pollutri D, Patrizi C, La Bella T, Marinelli S, Casadei Gardini A, Marisi G, Baron Toaldo M, Baglioni M, Salvatore V, et al. 2017. In Hepatocellular Carcinoma miR-221 modulates sorafenib resistance through inhibition of Caspase-3–Mediated Apoptosis. Clin Cancer Res. 23(14):3953–3965. DOI:10.1158/1078-0432.CCR-16-1464
   PubMed Web of Science ®Google Scholar
• Jankowsky E. 2011. RNA helicases at work: binding and rearranging. Trends Biochem Sci. 36(1):19–29. DOI:10.1016/j.tibs.2010.07.008
   PubMed Web of Science ®Google Scholar
• Lafontaine DL. 2015. Noncoding RNAs in eukaryotic ribosome biogenesis and function. Nat Struct Mol Biol. 22(1):11–19. DOI:10.1038/nsmb.2939
   PubMed Web of Science ®Google Scholar
• Wang H, Ma P, Liu P, Chen B, Liu Z. 2018. Small nucleolar RNA U2_19 promotes hepatocellular carcinoma progression by regulating Wnt/β-catenin signaling. Biochem Biophys Res Commun. 500(2):351–356. DOI:10.1016/j.bbrc.2018.04.074
   PubMed Web of Science ®Google Scholar
• Wu L, Zheng J, Chen P, Liu Q, Yuan Y. 2017. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway. Bio Pharmaco. 90:705–712. DOI:10.1016/j.biopha.2017.04.014
   Google Scholar
• Li C, Wu L, Liu P, Li K, Zhang Z, He Y, Liu Q, Jiang P, Yang Z, Liu Z, et al. 2020. The C/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates Hepatocarcinogenesis by stabilizing CDK1. Theranostics. 10(20):9348–9363. DOI:10.7150/thno.47677
   PubMed Web of Science ®Google Scholar
• Gorski JJ, Pathak S, Panov K, Kasciukovic T, Panova T, Russell J, Zomerdijk JC. 2007. A novel TBP-associated factor of SL1 functions in RNA polymerase I transcription. Embo J. 26(6):1560–1568. DOI:10.1038/sj.emboj.7601601
   PubMed Web of Science ®Google Scholar